Viewing Study NCT06484920


Ignite Creation Date: 2025-12-25 @ 4:23 AM
Ignite Modification Date: 2026-01-23 @ 6:25 AM
Study NCT ID: NCT06484920
Status: RECRUITING
Last Update Posted: 2025-02-03
First Post: 2024-06-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase II Study of the Combination of Pembrolizumab and ATRA Combination Treatment of Relapsed HL and B-NHL
Sponsor:
Organization: